ACOR Financial Facts

Interest and amortization of debt discount expense: -4.4M
Net sales: 128.51M
See Full Income Statement

Non-current portion of deferred cost of license revenue: 2.43M
Other current assets: 4.86M
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

| Expand Research on ACOR

Next EPS Date	N/A	EPS Growth Rate	N/A
Average EPS % Beat Rate	-188.2%	Revenue Growth Rate	N/A
Average % Move 1-Wk after EPS	-8.4%	Normal Earnings Time	After Close

Date	Qtr	EPS	Cons.	Surprise	Revs	Cons.	Gd.	1-Week %	1-Day %	Details
8/8/23	Q223	-$7.55	N/A	N/A	$29.68M	N/A	N/A			Details
5/11/23	Q123	-$0.69	N/A	N/A	$22.25M	N/A	N/A			Details
5/4/23	Q123	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
3/9/23	Q422	N/A	-$0.15	N/A	N/A	$35M	N/A	N/A	N/A
3/6/23	Q422	N/A	-$0.15	N/A	N/A	$35M	N/A	N/A	N/A
2/27/23	Q422	N/A	-$0.15	N/A	N/A	$35M	N/A	N/A	N/A
2/20/23	Q422	N/A	-$0.15	N/A	N/A	$35M	N/A	N/A	N/A
2/16/23	Q422	N/A	-$0.15	N/A	N/A	$35M	N/A	N/A	N/A

11/8/22	Q322	N/A	-$0.10	N/A	N/A	$30.5M	N/A	N/A	N/A
8/4/22	Q222	-$3.15	-$0.36	-$2.79	$18.2M	$29.1M	N/A			Details
3/9/22	Q421	-$0.67	N/A	N/A	$36.97M	$31.01M	N/A			Details
11/9/21	Q321	-$1.43	-$1.56	+$0.13	$31.45M	$30.57M	N/A			Details
8/5/21	Q221	-$1.87	-$2.09	+$0.22	$31.78M	$29.94M	N/A			Details
5/6/21	Q121	-$2.46	-$2.54	+$0.08	$28.86M	$22.15M	N/A			Details
3/4/21	Q420	-$2.50	-$1.48	-$1.02	$38.16M	$34M	N/A			Details
11/3/20	Q320	-$0.23	-$0.30	+$0.07	$53.09M	$29.59M	N/A			Details
8/4/20	Q220	-$0.35	-$0.48	+$0.13	$33.62M	$27.4M	N/A			Details
5/5/20	Q120	-$0.51	-$0.35	-$0.16	$28M	$41.01M	N/A			Details
2/13/20	Q419	-$0.15	-$0.40	+$0.25	$50.5M	$44.58M	=			Details
11/4/19	Q319	-$0.46	-$0.51	+$0.05	$47.7M	$44.72M	=			Details
8/1/19	Q219	-$0.58	-$1.06	+$0.48	$50.05M	$28.82M	=			Details
5/2/19	Q119	-$0.56	-$0.94	+$0.38	$44.14M	$33.04M	=			Details
2/14/19	Q418	$0.45	-$0.63	+$1.08	$69.2M	$48.1M	=			Details
10/31/18	Q318	$0.17	-$0.02	+$0.19	$142.81M	$82.81M	=			Details
8/2/18	Q218	$1.40	$0.72	+$0.68	$153.3M	$138.63M	=			Details
5/2/18	Q118	$0.14	$0.47	-$0.33	$106.2M	$129.87M	=			Details
2/15/18	Q417	$0.61	$1.05	-$0.44	$188.4M	$174.75M	=			Details
10/31/17	Q317	$0.43	$0.65	-$0.22	$141.07M	$150.64M	=			Details
7/27/17	Q217	$0.29	$0.48	-$0.19	$139.44M	$140.07M	=			Details
4/27/17	Q117	-$0.08	$0.09	-$0.17	$119.4M	$127.34M	=			Details
2/14/17	Q416	$0.05	$0.11	-$0.06	$140.63M	$137.9M	=			Details
10/27/16	Q316	-$0.04	$0.11	-$0.15	$135.61M	$134.01M	N/A			Details
7/28/16	Q216	$0.07	$0.18	-$0.11	$127.5M	$128.33M	N/A			Details
4/28/16	Q116	$0.07	$0.08	-$0.01	$115.9M	$115.36M	N/A			Details
2/11/16	Q415	$0.28	$0.22	+$0.06	$130.9M	$128.24M	N/A			Details
10/22/15	Q315	$0.31	$0.15	+$0.16	$148.2M	$115.52M	N/A			Details
7/30/15	Q215	$0.31	$0.17	+$0.14	$105.5M	$110.84M	N/A			Details
4/30/15	Q115	$0.15	$0.14	+$0.01	$99.85M	$100.2M	N/A			Details
2/12/15	Q414	$0.46	$0.14	+$0.32	$117.9M	$110.8M	N/A			Details
10/30/14	Q314	$0.28	$0.05	+$0.23	$106M	$94.7M	N/A			Details
7/31/14	Q214	$0.42	$0.15	+$0.27	$97.13M	$91.4M	N/A			Details
5/6/14	Q114	$0.21	$0.09	+$0.12	$80.52M	$81.3M	N/A			Details
2/13/14	Q413	$0.32	$0.18	+$0.14	$92.59M	$89.96M	N/A			Details
10/31/13	Q313	$0.36	$0.13	+$0.23	$84.92M	$90.01M	N/A			Details
8/1/13	Q213	$0.25	$0.09	+$0.16	$87.05M	$82.57M	N/A			Details
5/2/13	Q113	$0.09	$0.13	-$0.04	$62.3M	$80.71M	N/A			Details
2/13/13	Q412	$0.24	$0.15	+$0.09	$81.47M	$78.9M	N/A			Details
10/31/12	Q312	$0.38	$0.10	+$0.28	$77.44M	$75.2M	N/A			Details
7/31/12	Q212	$0.27	$0.12	+$0.15	$75.66M	$72.55M	N/A			Details
5/3/12	Q112	$0.36	$0.18	+$0.18	$71.25M	$70.95M	N/A			Details
2/16/12	Q411	$0.45	$0.18	+$0.27	$72.64M	$69.16M	N/A			Details
11/4/11	Q311	$0.40	$0.73	-$0.33	$93.03M	$90.78M	N/A			Details
8/1/11	Q211	$0.19	$0.12	+$0.07	$65.28M	$66.29M	N/A			Details
5/5/11	Q111	$0.08	$0.18	-$0.10	$61.29M	$64.25M	N/A			Details
2/17/11	Q410	$0.09	$0.17	-$0.08	$66.8M	$64.26M	N/A			Details
11/1/10	Q310	$0.31	-$0.13	+$0.44	N/A	N/A	N/A			Details

ACOR Financial Facts

Acorda Therapeutics, Inc. (ACOR) Earnings

Free News Feed